59.35
前日終値:
$60.49
開ける:
$59.34
24時間の取引高:
3.91M
Relative Volume:
1.72
時価総額:
$9.46B
収益:
$705.14M
当期純損益:
$-453.90M
株価収益率:
-19.52
EPS:
-3.04
ネットキャッシュフロー:
$-551.29M
1週間 パフォーマンス:
+39.25%
1か月 パフォーマンス:
+36.59%
6か月 パフォーマンス:
+80.12%
1年 パフォーマンス:
+24.55%
Ionis Pharmaceuticals Inc Stock (IONS) Company Profile
名前
Ionis Pharmaceuticals Inc
セクター
電話
(760) 931-9200
住所
2855 GAZELLE COURT, CARLSBAD, CA
IONS を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
IONS
Ionis Pharmaceuticals Inc
|
59.35 | 9.16B | 705.14M | -453.90M | -551.29M | -3.04 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Ionis Pharmaceuticals Inc Stock (IONS) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-07-31 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2025-07-01 | アップグレード | Barclays | Equal Weight → Overweight |
2025-04-07 | 開始されました | H.C. Wainwright | Buy |
2025-03-31 | 開始されました | Redburn Atlantic | Neutral |
2024-08-02 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
2024-07-24 | アップグレード | Leerink Partners | Market Perform → Outperform |
2024-07-16 | 再開されました | Jefferies | Buy |
2024-06-14 | アップグレード | Bernstein | Underperform → Mkt Perform |
2024-04-10 | アップグレード | Wolfe Research | Peer Perform → Outperform |
2024-01-02 | アップグレード | BofA Securities | Neutral → Buy |
2023-10-23 | アップグレード | BofA Securities | Underperform → Neutral |
2023-09-29 | 開始されました | Raymond James | Strong Buy |
2023-07-31 | アップグレード | Citigroup | Neutral → Buy |
2023-06-07 | 再開されました | Piper Sandler | Overweight |
2023-05-04 | アップグレード | Citigroup | Sell → Neutral |
2023-03-21 | 開始されました | Bernstein | Underperform |
2022-12-21 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2022-09-09 | 再開されました | Morgan Stanley | Overweight |
2022-07-18 | 再開されました | Oppenheimer | Outperform |
2022-03-31 | 再開されました | Piper Sandler | Overweight |
2022-03-01 | 開始されました | Citigroup | Sell |
2022-03-01 | 開始されました | Guggenheim | Buy |
2022-02-01 | ダウングレード | BofA Securities | Buy → Underperform |
2021-12-14 | アップグレード | William Blair | Mkt Perform → Outperform |
2021-05-07 | アップグレード | UBS | Sell → Neutral |
2021-03-01 | アップグレード | Barclays | Underweight → Equal Weight |
2020-12-16 | 開始されました | UBS | Sell |
2020-12-15 | アップグレード | Cowen | Market Perform → Outperform |
2020-09-14 | 再開されました | JP Morgan | Neutral |
2020-09-02 | 開始されました | The Benchmark Company | Hold |
2020-06-01 | 再開されました | Oppenheimer | Outperform |
2020-05-13 | 開始されました | RBC Capital Mkts | Outperform |
2020-03-05 | 開始されました | Citigroup | Buy |
2019-12-13 | 開始されました | Oppenheimer | Outperform |
2019-11-13 | 開始されました | BofA/Merrill | Buy |
2019-11-07 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
2019-09-10 | アップグレード | Bernstein | Mkt Perform → Outperform |
2018-08-08 | 繰り返されました | Stifel | Hold |
2018-08-07 | 繰り返されました | Stifel | Hold |
2018-05-08 | ダウングレード | Evercore ISI | Outperform → In-line |
2017-10-06 | 再開されました | Goldman | Sell |
2017-08-17 | 開始されました | Evercore ISI | Outperform |
2017-08-09 | 繰り返されました | Stifel | Hold |
2017-03-10 | ダウングレード | Goldman | Neutral → Sell |
2016-12-28 | 繰り返されました | BMO Capital Markets | Outperform |
2016-12-27 | 繰り返されました | Leerink Partners | Mkt Perform |
すべてを表示
Ionis Pharmaceuticals Inc (IONS) 最新ニュース
Ionis Pharmaceuticals CEO Monia sells $12.3 million in IONS stock - Investing.com
Ionis pharma EVP O’Neil sells $5.39 million in IONS stock - Investing.com
Ionis Pharma EVP Geary sells $503,671 in IONS stock - Investing.com
Ionis Pharmaceuticals director sells $1.6m in IONS stock - Investing.com
Ionis Pharma director Klein sells $1.68 million in shares - Investing.com
Ionis Pharma (IONS) Hits New High Anew as Analyst Sees Blockbuster Potential for Olezarsen - Yahoo Finance
Ionis Pharmaceuticals’ Strategic Position in the Biotech Sector: Growth Potential in Therapeutic Innovation and Market Leadership - AInvest
What drives Ionis Pharmaceuticals Inc.’s stock price2025 Volume Leaders & Proven Capital Preservation Methods - khodrobank.com
Is Ionis Pharmaceuticals Inc. forming a double bottomWeekly Trading Summary & AI Based Trade Execution Alerts - khodrobank.com
RBC Capital Adjusts Price Target on Ionis Pharmaceuticals to $80 From $70, Maintains Outperform Rating - MarketScreener
How to use a screener to detect Ionis Pharmaceuticals Inc. breakoutsWeekly Stock Summary & Daily Volume Surge Signals - Newser
When is the best time to exit Ionis Pharmaceuticals Inc.July 2025 Momentum & Fast Entry High Yield Stock Tips - Newser
Market reaction to Ionis Pharmaceuticals Inc.’s recent newsMarket Trend Summary & Reliable Momentum Entry Alerts - Newser
What’s next for Ionis Pharmaceuticals Inc. stock priceDollar Strength & Community Driven Trade Alerts - Newser
Street Watch: Is Ionis Pharmaceuticals Inc. a cyclical or defensive stockJuly 2025 Catalysts & Consistent Profit Trade Alerts - khodrobank.com
Ionis Pharmaceuticals Executives Buy Shares Amid Recent Market Volatility. - AInvest
Amyotrophic Lateral Sclerosis Pipeline Outlook 2025: Clinical - openPR.com
Ionis Pharmaceuticals Shares Rise After BMO Capital Upgrade - MarketScreener
Key resistance and support levels for Ionis Pharmaceuticals Inc.M&A Rumor & Daily Stock Trend Reports - Newser
What the charts say about Ionis Pharmaceuticals Inc. todayQuarterly Profit Report & Free Weekly Watchlist of Top Performers - Newser
Citigroup maintains Buy rating, raises Ionis Pharmaceuticals PT to $84 from $69. - AInvest
Is Ionis Pharmaceuticals Inc. stock trending bullish2025 Breakouts & Breakdowns & High Accuracy Trade Signal Alerts - khodrobank.com
Ionis Pharma (IONS) Touches New High on Promising Olezarsen Results - MSN
IONS Hits 52-Week High on Tryngolza's Success in Lowering Triglyceride - Yahoo Finance
Ionis Pharmaceuticals: BMO Capital Upgrades to Outperform, PT Raised to $70 - AInvest
Ionis Pharmaceuticals Soars: New Drug Approved - StocksToTrade
Buy IONS Stock After Its 35% Pop? - Trefis
Ionis upgraded at BMO Capital Markets after data for lipid-lowering agent - MSN
Ionis stock upgraded at BMO Capital Markets (IONS:NASDAQ) - Seeking Alpha
Analyzing Ionis Pharmaceuticals Inc. with risk reward ratio charts2025 Major Catalysts & Community Verified Swing Trade Signals - Newser
Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) 34% Share Price Surge Not Quite Adding Up - simplywall.st
Using data filters to optimize entry into Ionis Pharmaceuticals Inc.Buy Signal & Accurate Entry/Exit Alerts - Newser
Ionis Pharmaceuticals Inc. stock prediction for this week2025 Support & Resistance & Low Risk Profit Maximizing Plans - Newser
MSD, Ionis trumpet lipid-lowering drug data - pharmaphorum
Ionis Pharmaceuticals stock rating upgraded by BMO Capital on blockbuster potential - Investing.com
BMO Capital Upgrades Ionis Pharmaceuticals to Outperform From Market Perform, Adjusts PT to $70 From $40 - MarketScreener
Will Ionis Pharmaceuticals Inc. bounce back from current supportPortfolio Value Report & Expert Approved Momentum Ideas - Newser
Ionis reports topline outcomes from Phase III trials of olezarsen for sHTG - Yahoo Finance
Ionis Pharmaceuticals shares rise 1.74% premarket after positive Phase 3 study results for olezarsen. - AInvest
Has Ionis Pharmaceuticals Inc. formed a bullish divergenceBuy Signal & Fast Entry Momentum Alerts - Newser
Ionis to present at upcoming September 2025 investor conferences - BioSpace
What are Ionis Pharmaceuticals Inc.’s earnings expectationsRecession Risk & Trade Opportunity Analysis Reports - khodrobank.com
Comparing Ionis Pharmaceuticals Inc. in custom built stock radarsWeekly Profit Summary & AI Optimized Trade Strategies - Newser
Ionis looks to expand use of lipid-lowering drug after trial hits goal - BioPharma Dive
Narrow-Moat Ionis Expands Its Cardiology and Neurology Portfolio; Positive Long-Term Outlook - Morningstar
Visualizing Ionis Pharmaceuticals Inc. stock with heatmaps2025 Top Gainers & Daily Profit Maximizing Tips - Newser
Ionis reports sHTG win while Arrowhead inks Novartis deal - BioWorld MedTech
IONS Stock Soars: Time to Buy or Stay Cautious? - timothysykes.com
More Ways to Cut Cholesterol, Triglycerides Are Coming. This Stock Took Off. - Barron's
Ionis Looks Set To Own Its First Blockbuster - insights.citeline.com
Ionis to present at upcoming investor conferences - Business Wire
Ionis Pharmaceuticals Inc (IONS) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):